Nebulizer to treat cystic fibrosis

Scientific observation of surfers with cystic fibrosis (CF) has led to the discovery that the inhaled mist of seawater has a therapeutic effect on the lung problems associated with the disease. These findings are now being used by pharmaceutical company Parion Sciences and product development firm Cambridge Consultants in a revolutionary new aerosol delivery system, which enables CF sufferers to get the benefits of saltwater treatment at home while they sleep. “We have seen evidence that routine exposure to salt water reduces the number of lung infections in CF patients and leads to fewer hospital admissions – but the challenge was to develop an optimal delivery system,” says Dr. Richard Boucher, cofounder and chairman of Parion. read more
Source: Articles from MedicalDesign.com - Category: Medical Equipment Tags: Products Source Type: news